North Carolina Mesothelioma Doctors, Cancer Centers and Treatment

Mesothelioma patients who live in North Carolina have access to quality mesothelioma treatment in state. Conventional mesothelioma treatments available in North Carolina include surgery, chemotherapy, and radiation. Additionally, clinical trials may currently be recruiting mesothelioma patients in North Carolina.

We provide a list of top mesothelioma doctors that practice in North Carolina, as well as the top cancer care centers in the state. A list of local cancer support services has been included as well for your convenience. Learn more about health care options available in North Carolina below.

Mesothelioma Cancer Centers in North Carolina

We have compiled a list of mesothelioma cancer centers in North Carolina. Please click on a cancer center link for more information about the clinical programs offered, affiliated mesothelioma doctors and how to contact the cancer center.

Doctors who Treat Mesothelioma in North Carolina

We have compiled a list of mesothelioma doctors that practice in the state of North Carolina. Please click on a doctor link to obtain more information about his/her background, areas of expertise, professional affiliations, and office locations.

It is not uncommon for patients to travel outside of their current states to meet with top oncologists and thoracic surgeons across the country. These mesothelioma experts usually have a particular focus within their practice.

Mesothelioma Clinical Trials in North Carolina

The following clinical trials are in progress or actively recruiting participants in the state of North Carolina:

• Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

  Conditions:	Acinar Cell Carcinoma; Adenoid Cystic Carcinoma; Adrenal Cortex Carcinoma; Adrenal Gland Pheochromocytoma; Anal Canal Neuroendocrine Carcinoma; Anal Canal Undifferentiated Carcinoma; Angiosarcoma; Apocrine Neoplasm; Appendix Mucinous Adenocarcinoma; Bartholin Gland Transitional Cell Carcinoma; Basal Cell Carcinoma; Bladder Adenocarcinoma; Cervical Adenocarcinoma; Cervical Clear Cell Adenocarcinoma; Cholangiocarcinoma; Chordoma; Colorectal Squamous Cell Carcinoma; Desmoid-Type Fibromatosis; Endometrial Transitional Cell Carcinoma; Endometrioid Adenocarcinoma; Esophageal Neuroendocrine Carcinoma; Esophageal Undifferentiated Carcinoma; Extrahepatic Bile Duct Carcinoma; Extramammary Paget Disease; Fallopian Tube Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fibromyxoid Tumor; Gallbladder Carcinoma; Gastric Neuroendocrine Carcinoma; Gastric Squamous Cell Carcinoma; Gastric Undifferentiated Carcinoma; Gastrointestinal Stromal Tumor; Gestational Trophoblastic Tumor; Giant Cell Carcinoma; Intestinal Neuroendocrine Carcinoma; Intrahepatic Cholangiocarcinoma; Lung Carcinoid Tumor; Lung Sarcomatoid Carcinoma; Major Salivary Gland Carcinoma; Malignant Odontogenic Neoplasm; Malignant Peripheral Nerve Sheath Tumor; Malignant Testicular Sex Cord-Stromal Tumor; Metaplastic Breast Carcinoma; Metastatic Malignant Neoplasm of Unknown Primary; Minimally Invasive Lung Adenocarcinoma; Mixed Mesodermal (Mullerian) Tumor; Mucinous Adenocarcinoma; Mucinous Cystadenocarcinoma; Nasal Cavity Adenocarcinoma; Nasal Cavity Carcinoma; Nasopharyngeal Carcinoma; Nasopharyngeal Papillary Adenocarcinoma; Nasopharyngeal Undifferentiated Carcinoma; Oral Cavity Carcinoma; Oropharyngeal Undifferentiated Carcinoma; Ovarian Adenocarcinoma; Ovarian Clear Cell Adenocarcinoma; Ovarian Germ Cell Tumor; Ovarian Mucinous Adenocarcinoma; Ovarian Squamous Cell Carcinoma; Ovarian Transitional Cell Carcinoma; Pancreatic Acinar Cell Carcinoma; Pancreatic Neuroendocrine Carcinoma; Paraganglioma; Paranasal Sinus Adenocarcinoma; Paranasal Sinus Carcinoma; Parathyroid Gland Carcinoma; PEComa; Peritoneal Mesothelioma; Pituitary Gland Carcinoma; Placental Choriocarcinoma; Primary Peritoneal High Grade Serous Adenocarcinoma; Pseudomyxoma Peritonei; Rare Disorder; Scrotal Squamous Cell Carcinoma; Seminal Vesicle Adenocarcinoma; Seminoma; Serous Cystadenocarcinoma; Small Intestinal Adenocarcinoma; Small Intestinal Squamous Cell Carcinoma; Solid Neoplasm; Spindle Cell Neoplasm; Squamous Cell Carcinoma of the Penis; Teratoma With Somatic-Type Malignancy; Testicular Non-Seminomatous Germ Cell Tumor; Thyroid Gland Carcinoma; Tracheal Carcinoma; Transitional Cell Carcinoma; Ureter Adenocarcinoma; Ureter Squamous Cell Carcinoma; Urethral Adenocarcinoma; Urethral Squamous Cell Carcinoma; Vaginal Adenocarcinoma; Vaginal Squamous Cell Carcinoma, Not Otherwise Specified; Vulvar Carcinoma
  Last Updated:	July 8, 2019
  Status:	Recruiting
  Locations:	Asheville, NC. Clinton, NC. Clyde, NC. Goldsboro, NC. Hendersonville, NC. Jacksonville, NC. Wilson, NC. Birmingham, AL. Mobile, AL. Anchorage, AK.

• Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

  Conditions:	Unresectable Pleural or Peritoneal Malignant Mesothelioma
  Last Updated:	July 2, 2019
  Status:	Active, not recruiting
  Locations:	Durham, NC. Scottsdale, AZ. La Jolla, CA. Los Angeles, CA. San Francisco, CA. Santa Monica, CA. New Haven, CT. Newark, DE. Tampa, FL. Augusta, GA.

• Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

  Conditions:	Advanced Solid Tumors
  Last Updated:	June 20, 2019
  Status:	Active, not recruiting
  Locations:	Durham, NC. Edmonton, Alberta. New York, NY. Toronto, Ontario. Houston, TX. San Antonio, TX. Salt Lake City, UT.

• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

  Conditions:	Advanced Malignancies; Metastatic Cancer
  Last Updated:	June 19, 2019
  Status:	Recruiting
  Locations:	Chapel Hill, NC. Los Angeles, CA. Gainesville, FL. Detroit, MI. Saint Louis, MO. Hackensack, NJ. New York, NY. Oklahoma City, OK. Portland, OR. Philadelphia, PA.

• Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

  Conditions:	Mesothelioma
  Last Updated:	June 6, 2019
  Status:	Active, not recruiting
  Locations:	Durham, NC. Calgary, Alberta. La Jolla, CA. Aurora, CO. Norwich, CT. Tampa, FL. Chicago, IL. New Orleans, LA. Bethesda, MD. Rochester, MN.

Find Cancer Support Services in North Carolina

Cancer support services for mesothelioma patients include patient transport, temporary housing, physical therapy and counseling. The following local services may be of help to you while you are receiving treatment for mesothelioma in North Carolina.

Free 2019 Mesothelioma Treatment Guide & Books

Delivered to you within 24 hours